Analyst Upgrades

• Auriga upgraded Leap Wireless (LEAP) to buy from hold following the company's Q2 results and analyst day, citing valuation, longer-term potential for consolidation and prospects for business improvements. Despite upgrading, the firm lowered its target for shares to $16 from $19.
• Goldman upgraded Barnes & Noble (BKS) to neutral from sell following the company's announcement to explore strategic alternatives. The firm raised its price target to $15 from $12.
• RBC Capital upgraded ESCO Technologies (ESE) to sector perform from underperform following the better-than-expected Q3 report. The firm raised its price target to $30 from $28.
• MetLife (MET) was upgraded to buy from neutral at BofA/Merrill.
• Priceline.com (PCLN) was upgraded to buy from hold at Stifel Nicolaus.
• HSBC (HBC) was upgraded to outperform from underperform at CLSA.

Analyst Upgrades

• Citigroup upgraded FMC Technologies (FTI) to buy from hold, citing pent-up deepwater drilling demand and valuation. Despite upgrading, the firm lowered its target for shares to $69 from $77.
• Piper Jaffray upgraded Valeant (VRX) to overweight from neutral following the company's merger with Biovail (BVF) and raised its target for shares to $53 from $43.
• Deutsche Bank upgraded Lincare Holdings (LNCR) to buy from hold, citing valuation and the company's dividend initiation. The firm upped its target for shares to $37 from $35.
• Ariba (ARBA) was upgraded to overweight from neutral at JPMorgan.
• Crucell (CRXL) was upgraded to buy from hold at RBS.
• ENI SpA (E) was upgraded to buy from neutral at Goldman.

From 2004 to 2008, the total gross floor area of residential properties sold in China increased at 13.4% annually. Some of the drivers included: improved property rights, government reforms, rapid urbanization and rising affluence.

As a result, there is lots of demand for useful real estate data and consulting services. And, the leading provider is China Real Estate Information.

Well, today the company went public in the US, raising $216 million. The IPO price was $12 (between the price range of $11.80 to $13.80). So far in today's trading, the shares of China Real Estate are up 15% to $13.80.

This post is part of a special annual report -- Top Stock Picks '09 -- in which TheStockAdvisors.com asked 75 leading newsletter advisors to select their favorite investment for the new year.

Italy's Eni SPA ADR (NYSE: E) has one of the most successful and fastest-growing E&P operations of any major integrated energy firm," says energy expert Elliott Gue.

In his The Energy Strategist, he notes, "And despite its defensive characteristics, Eni offers an impressive 8.5%, the highest of the large integrated oils."

"ENI derives close to three-quarters of its operating income from exploration and production (E&P) and just 3.8% from refining and marketing.

"Thus, Eni has more leverage to E&P than most large integrated energy firms and less exposure to refining margins. The company's other main business is gas and power, accounting for close to 22% of operating income.

"Eni has one of the most successful and fastest-growing E&P operations of any major integrated energy firm. In the third quarter, Eni's production grew to 1.764 million barrels of oil equivalent per day (boe/d), up 6.3% over the same quarter a year ago, the fastest growth of any integrated firm in my coverage universe.

"And Eni has a large number of new projects scheduled to come onstream over the next three years that are poised to power further production growth.

MOST NOTEWORTHY: UBS AG, Coventry Health, Express Scripts and Medco Health were today's noteworthy downgrades:

• Credit Suisse downgraded shares of UBS (NYSE:UBS) to Neutral from Outperform as they believe UBS will have difficulty rebuilding the franchise and do not expect a quick recovery for its private bank unit.
  
• Wachovia downgraded Coventry Health (NYSE:CVH) to Market Perform from Outperform citing concerns regarding visibility around higher than expected inpatient/outpatient costs following reduced 2008 guidance.
  
• UBS downgraded Express Scripts (NASDAQ:ESRX) and Medco Health to Neutral from Buy citing the Pfizer (NYSE:PFE)/Ranbaxy settlement, which reduces the likelihood of a generic Lipitor launch in 2010.

OTHER DOWNGRADES:

• Goldman downgraded ENI SpA (NYSE:E) to Neutral from Buy and removed the stock from the Pan-Europe Conviction Buy List.
  
• Huntsman (NYSE:HUN) was downgraded to Underperform from hold at Jefferies.
  
• Commercial Metals (NYSE:CMC) was cut at Citigroup to Hold from Buy.

MOST NOTEWORTHY: Lukoil, ENI SpA and Meritage were today's noteworthy upgrades:

• Citigroup upgraded shares of Lukoil (OTC: LUKOY) to Buy from Hold on valuation, as they believe the company's oil production, refineries and gas stations outside of Russia are not priced into shares.
  
• ABN Amro raised ENI SpA (NYSE: E) to Hold from Sell after a meeting with management.
  
• Meritage (NYSE: MTH) was upgraded to Buy from Neutral at UBS on strong results.

OTHER UPGRADES:

• Morgan Stanley upgraded Corporate Executive (NASDAQ: EXBD) to Equal Weight from Underweight.
  
• Trico Marine Services (NASDAQ: TRMA) was upgraded to Overweight from Equal Weight at Lehman.
  
• Holly Corp. (NYSE: HOC) was raised to Outperform from Market Perform at BMO Capital.

MOST NOTEWORTHY: The software sector, Ericsson, Paccar, Eni SpA and Valueclick were today's noteworthy downgrades:

• Bear Stearns downgraded the software sector to Underweight from Market Weight, citing valuations and increased risk to 2008 IT budgets.
  
• Ericsson (NASDAQ: ERIC) was downgraded to Equal Weight from Overweight at Lehman and to Neutral from Overweight at JP Morgan following the company's Q3 profit warning.
  
• Paccar (NASDAQ: PCAR) was downgraded to Underperform from Market Perform at Wachovia. The firm believes Street estimates are too high due to weaker-than-expected North American unit production.
  
• ABN Amro downgraded shares of Eni SpA (NYSE: E) to Sell from Hold as they expect the company to invest significantly more in its upstream activities than guidance suggests due to cost pressures.
  
• Oppenheimer downgraded ValueClick (NASDAQ: VCLK) to Neutral from Buy following the Q3 pre-announcement and guidance.

OTHER DOWNGRADES:

• Merrill downgraded Equity Lifestyle Properties (NYSE: ELS) to Neutral from Buy.
  
• Autodesk (NASDAQ: ADSK) was downgraded to Neutral from Buy at UBS.
  
• JP Morgan downgraded ACA Capital Holdings (NYSE: ACA) To Neutral from Overweight.
  
• Citigroup downgraded Vimpel Communications (NYSE: VIP) to Sell from Hold.
  
• Yahoo! (NASDAQ: YHOO) was downgraded to Hold from Buy at Gabelli.

MOST NOTEWORTHY: General Motors, Green Mountain Coffee, Orexigen and Norsk Hydro were today's noteworthy upgrades:

• Banc of America upgraded shares of General Motors Corporation (NYSE: GM) to Neutral from Sell as they believe the agreement with the United Auto Workers union offsets a worsening outlook for sales.
  
• Piper Jaffray upgraded shares of Green Mountain Coffee Roasters (NASDAQ: GMCR) to Outperform from Market Perform after a meeting with management as they believe shares offer a compelling buying opportunity at current levels based on their 2009 estimates.
  
• JMP Securities upgraded shares of Orexigen Therapeutics (NASDAQ: OREX) to Strong Buy from Market Outperform as they believe the company's lead product candidates, Empatic and Contrave, could become front-line therapies for obesity due to improved durability of efficacy, increased safety and tolerability, and lack of addiction.
  
• Norsk Hydro (NYSE: NHY) was upgraded to Buy from Hold at Citigroup. The firm sees upside in the stock from the volume growth and further improvements in downstream operations.

OTHER UPGRADES:

• Lehman upgraded Temple Inland (NYSE TIN) to Overweight from Equal Weight.
  
• Ciena Corporation (NASDAQ: CIEN) was upgraded to Buy from Neutral at Merrill Lynch.
  
• HSBC upgraded ENI SpA (NYSE: E) to Overweight from Neutral.
  
• Nollenberger raised shares of Symyx Technologies (NASDAQ: SMMX) to Buy from Neutral.

Following the lead of other states including Missouri and New Jersey, Ohio Treasurer Richard Cordray announced that Ohio will no longer invest in companies that support terrorism. What a bold stand!

This did cause me to wonder what stocks are so stigmatized. Missouri uses a screen developed by the Conflict Securities Advisory Group (CSAG). On its no-spend list are companies that deal with the countries on the U.S. government's list of terrorist states: Cuba, North Korea, Iran, Syria and Sudan.

While the names of the companies that appear on CSAG's screen is proprietary, Missouri's 'don't-own' list includes Royal Dutch Shell (NYSE: RDS.A), Gazprom, Siemens (NYSE: SI), Hyundai, Total (NYSE: TOT), and ENI (NYSE: E), all foreign-owned. However, Coca-Cola (NYSE: KO) does show up on some lists.

A leader in this effort is New York Comptroller William Thompson. With the cooperation of the ultra-well connected Conflicts Security Advisory Group, he has convinced American corporations such as Halliburton Co. (NYSE: HAL) to refuse deals with the aforementioned countries rather than fight shareholder resolutions on the matter.

For personal investors concerned about this issue, the Roosevelt Anti-terror Multi-Cap Fund touts itself as 100% free of companies that deal with or support terrorists.